Devyser Diagnostics

96.50 SEK

+1.58%

Less than 1K followers

DVYSR

First North Stockholm

Medical Equipment & Services

Health Care

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Devyser Diagnostics

20212022202320242025
Revenue93.5126.6169.3216.9250.5
growth-%35.4 %33.7 %28.1 %15.5 %
EBITDA-21.2-43.445.8-51.037.2
EBIT-21.2-52.0-58.9-58.310.1
Profit before taxes-21.9-52.7-54.4-57.6-2.6
Net income-20.7-46.0-53.6-61.5-8.4
EPS-1.85-2.89-3.31-3.75-0.51
Dividend0.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %

Profitability and return on capital

20212022202320242025
EBITDA-%-22.7 %-34.3 %27.1 %-23.5 %14.9 %
EBIT-%-22.7 %-41.1 %-34.8 %-26.9 %4.0 %
ROE-5.0 %-10.7 %-13.9 %-17.6 %-2.4 %
ROI-4.5 %-9.2 %-10.5 %-13.0 %-1.8 %